Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?

American Journal of Kidney Diseases

Volumn 32, Issue 5, 1998, Pages 853-906

  Levey, A S ^a   Beto, J A ^a   Coronado, B E ^a   Eknoyan, G ^a   Foley, R N ^a   Kasiske, B L ^a   Klag, M J ^a   Mailloux, L U ^a   Manske, C L ^a   Meyer, K B ^a   Parfrey, P S ^a   Pfeifer, M A ^a   Wenger, N K ^a   Wilson, P W F ^a   Wright J T , Jr ^a   Willis, K ^a  

^a NATIONAL KIDNEY FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FOLIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; PROBUCOL; WARFARIN;

ANEMIA; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DIALYSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; PRACTICE GUIDELINE; REVIEW;

EID: 0031738068     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(98)70145-3     Document Type: Article

References (0)